High PriorityDeveloping
FDA Vaccine Panel Set to Review Moderna's mRNA Flu Shot
high consequenceUpdated 17m ago
Key takeaway: Moderna's progress in developing an mRNA flu vaccine signals a significant advancement in seasonal flu prevention strategies, with FDA recommendations expected soon.
